PCG
VRTX icon

Prosperity Consulting Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Prosperity Consulting Group’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$249K Sell
558
-835
-60% -$389K 0.01% 459
2025
Q4 		$632K Sell
1,393
-1,655
-54% -$713K 0.03% 323
2025
Q3 		$1.19M Buy
3,048
+98
+3% +$41K 0.06% 221
2025
Q2 		$1.31M Sell
2,950
-54
-2% -$24.9K 0.1% 188
2025
Q1 		$1.46M Buy
3,004
+85
+3% +$39.6K 0.11% 177
2024
Q4 		$1.18M Sell
2,919
-661
-18% -$306K 0.09% 206
2024
Q3 		$1.66M Buy
3,580
+2,688
+301% +$1.29M 0.13% 175
2024
Q2 		$418K Buy
+892
New +$387K 0.06% 211

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return